[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343139-105":59,"doc-detail-343139-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-gli1-and-bax-by-nanonoscapine-could-impede-prostate-adenocarcinoma-progression","Targeting GLI1 and BAX by nanonoscapine could impede prostate adenocarcinoma progression","","Prostate cancer remains a critical global health challenge requiring new therapeutic options. Noscapine, an opium-derived phthalide isoquinoline alkaloid, has anti-tumor activity but clinical use is limited by low bioavailability and possible side effects. This study evaluates nanonoscapine as a nanotechnology-enabled medication to improve delivery and efficacy, using the androgen-sensitive LNCaP prostate adenocarcinoma cell line.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-gli1-and-bax-by-nanonoscapine-could-impede-prostate-adenocarcinoma-progression/343139/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-gli1-and-bax-by-nanonoscapine-could-impede-prostate-adenocarcinoma-progression/343139.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address regarding prostate cancer treatment?","Question",{"text":112,"@type":113},"The study addresses the need for more effective therapies despite existing options and highlights that many patients still experience recurrence, with additional challenges from chemotherapy-related side effects and treatment resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does nanonoscapine affect prostate adenocarcinoma cells in the study?",{"text":117,"@type":113},"Nanonscapine inhibits LNCaP cell proliferation by inducing G2/M phase arrest and promoting apoptosis, supported by MTT assays, flow cytometry, and gene expression analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genes are targeted and why are they important?",{"text":121,"@type":113},"The study focuses on GLI1 and BAX, described as crucial regulators of cell cycle progression and apoptosis, and therefore relevant to cancer progression and therapeutic targeting.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343139,1790804804,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nTargeting GLI1 and BAX by nanonoscapine could impede prostate adenocarcinoma progression  \nMohammad Hossein Derakhshan Nazari1, Ronak Heidarian2, Mina Masoudnia3, Rana Askari Dastjerdi1, ParnianGhaedi Talkhounche4 & Sara Taleahmad5*  \nProstate cancer as a critical global health issue, requires the exploration of a novel therapeutic approach. Noscapine, an opium-derived phthalide isoquinoline alkaloid, has shown promise in cancer treatment thanks to its anti-tumorigenic properties. However, limitations such as low bioavailability and potential side effects have hindered its clinical application. This study introduces nanonoscapine as a novel medication to overcome these challenges, leveraging the advantages of improved drug delivery and efficacy achieved in nanotechnology. We monitored the effects of nanonoscapine on the androgen-sensitive human prostate adenocarcinoma cell line, LNCaP, investigating its impact on GLI1 and BAX genes’ expressions, crucial regulators of cell cycle and apoptosis. Our findings, from MTT assays, flow cytometry, and gene expression analyses, have demonstrated that nanonoscapine effectively inhibits prostate cancer cell proliferation by inducing G2/M phase arrest and apoptosis. Furthermore, through bioinformatics and computational analyses, we have revealed the underlying molecular mechanisms, underscoring the therapeutic potential of nanonoscapine in enhancing patient outcomes. This study highlights the significance of nanonoscapine as an alternative or adjunct treatment to conventional chemotherapy, warranting further investigation in clinical settings.  \nKeywords Noscapine nanoparticles, Cell cycle arrest, Tumor cell apoptosis, Bioinformatics  \nProstate cancer is the second most common type of cancer in men globally, with approximately 1,276,106 confirmed cases and a mortality rate of 358,989 in 2018. In the U.S. alone, it accounted for an estimated 191,930 new cases and 33,330 deaths in 2020, making it the fifth leading cause of cancer-related death1,2. Studies have identified age, genetic predispositions such as family history, hormonal balance, and environmental factors as primary risk factors for prostate cancer3. Different screening programs based on biopsy, prostate-specific antigen (PSA) examination, trans-rectal ultrasound, digital-rectal examination, and using biomarkers like 8-Hydroxy-2-Deoxyguanosine or 8-Iso-Prostaglandin F2α have been developed, helping the classification of patients to low, intermediate, and high-risk groups4–6. This classification incorporates the choice of treatments and frequency of surveillance. The therapy line begins with prostatectomy and radiotherapy alongside active observation. At the intermediate level often Androgen deprivation therapy (ADT) is also combined7. In the advanced and metastatic type of prostate cancer often the first line of treatment starts with chemotherapy and ADT8. The development of resistance to ADT or castration-resistant prostate cancer (CRPC) or metastasis to bones could lead to a shift of treatment to chemotherapy, and poly (ADP-ribose) polymerase inhibitors alongside other treatment methods9. Taken together, despite the advances in treatment options and screening tools, it has not eliminated the need for making more progress in finding new therapeutic ways, and approximately 30% of patients experience recurrence10. Considering the necessity for chemotherapy agents as one of the main options for prostate cancer treatment, side effects, and the probable resistance to growing through receiving the treatment, it is vital to develop agents with fewer complications.  \n1Department of Microbiology and Microbial Biotechnology, Faculty of Life Science and Biotechnology, Shahid Beheshti University, Tehran, Iran. 2Department of Developmental Biology, Kharazmi University, Tehran, Iran. 3Department of Immunology, School of Medicine, Shahid Beheshti University of Medic","cbCaiq233dA6pLlp","https://ap.wps.com/l/cbCaiq233dA6pLlp","pdf",4747929,13,"English","# Background\n## Rationale for targeting GLI1 and BAX\n## Limitations of conventional noscapine\n# Methods and Experimental Approach\n## Effects on LNCaP cells\n## Gene expression analysis\n## MTT assays and flow cytometry\n# Findings\n## Inhibition of proliferation\n## G2/M phase arrest\n## Induction of apoptosis\n# Mechanistic Insights\n## Bioinformatics and computational analyses\n# Implications and Future Work","[{\"question\":\"What problem does the study address regarding prostate cancer treatment?\",\"answer\":\"The study addresses the need for more effective therapies despite existing options and highlights that many patients still experience recurrence, with additional challenges from chemotherapy-related side effects and treatment resistance.\"},{\"question\":\"How does nanonoscapine affect prostate adenocarcinoma cells in the study?\",\"answer\":\"Nanonscapine inhibits LNCaP cell proliferation by inducing G2/M phase arrest and promoting apoptosis, supported by MTT assays, flow cytometry, and gene expression analyses.\"},{\"question\":\"Which genes are targeted and why are they important?\",\"answer\":\"The study focuses on GLI1 and BAX, described as crucial regulators of cell cycle progression and apoptosis, and therefore relevant to cancer progression and therapeutic targeting.\"}]","Targeting GLI1 and BAX by nanonoscapine could impede prostate adenocarcinoma progression | PDF",1790050053,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c654b5ea0231c38d15854e55cd31c1e0.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4f832197136e497db5fa7ce60389db3.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e21ad79321662483b82c32c5f683d075.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/434f1dd230b2c390d00ff94b26a9352f.webp",980,1287]